{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:32:58Z","timestamp":1792657978245,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jaut.2014.01.022","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T09:45:58Z","timestamp":1392025558000},"page":"134-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":289,"special_numbering":"C","title":["The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review"],"prefix":"10.1016","volume":"48-49","author":[{"given":"Dimitrios","family":"Karussis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9648","key":"10.1016\/j.jaut.2014.01.022_bib1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.022_bib2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis\u2013the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.022_bib3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/ni0901-762","article-title":"Multiple sclerosis: a two-stage disease","volume":"2","author":"Steinman","year":"2001","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.022_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2377-13-128","article-title":"Incidence and prevalence of multiple sclerosis in Europe: a systematic review","volume":"13","author":"Kingwell","year":"2013","journal-title":"BMC Neurol"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.022_bib5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"4943","key":"10.1016\/j.jaut.2014.01.022_bib6","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.1689076","article-title":"T\u00a0cells responsive to myelin basic protein in patients with multiple sclerosis","volume":"247","author":"Allegretta","year":"1990","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.022_bib7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.179.3.973","article-title":"Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis","volume":"179","author":"Zhang","year":"1994","journal-title":"J\u00a0Exp Med"},{"issue":"7534214","key":"10.1016\/j.jaut.2014.01.022_bib8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","article-title":"Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein","volume":"80","author":"Wucherpfennig","year":"1995","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2014.01.022_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.05.025","article-title":"Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens","volume":"226","author":"Venken","year":"2010","journal-title":"J\u00a0Neuroimmunol"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.022_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"issue":"Pt 7","key":"10.1016\/j.jaut.2014.01.022_bib11","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/awh486","article-title":"Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis","volume":"128","author":"Cepok","year":"2005","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.022_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1179\/016164106X98099","article-title":"The B cell response in multiple sclerosis","volume":"28","author":"Owens","year":"2006","journal-title":"Neurol Res"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.022_bib13","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W","article-title":"The role of B cells and autoantibodies in multiple sclerosis","volume":"47","author":"Archelos","year":"2000","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.022_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.410100205","article-title":"Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown","volume":"10","author":"Prineas","year":"1981","journal-title":"Ann Neurol"},{"issue":"Pt 4","key":"10.1016\/j.jaut.2014.01.022_bib15","first-page":"1089","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.022_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol"},{"issue":"21619943","key":"10.1016\/j.jaut.2014.01.022_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.autrev.2011.05.008","article-title":"Immune-mediated CNS diseases: a review on nosological classification and clinical features","volume":"11","author":"Zettl","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.022_bib18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/01.wnl.0000335764.14513.1a","article-title":"Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome","volume":"72","author":"Okuda","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.022_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1474-4422(05)70095-8","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.022_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1474-4422(05)70071-5","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol"},{"issue":"20187866","key":"10.1016\/j.jaut.2014.01.022_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/ern.10.9","article-title":"Diagnostic imaging in acute disseminated encephalomyelitis","volume":"10","author":"Brinar","year":"2010","journal-title":"Expert Rev Neurother"},{"issue":"17495616","key":"10.1016\/j.jaut.2014.01.022_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/WCO.0b013e3280f31b45","article-title":"Acute disseminated encephalomyelitis: an acute hit against the brain","volume":"20","author":"Menge","year":"2007","journal-title":"Curr Opin Neurol"},{"issue":"12601124","key":"10.1016\/j.jaut.2014.01.022_bib23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1212\/01.WNL.0000048493.82053.4C","article-title":"Acute hemorrhagic leukoencephalitis vs ADEM: FLAIR MRI and neuropathology findings","volume":"60","author":"Kuperan","year":"2003","journal-title":"Neurology"},{"issue":"15127316","key":"10.1016\/j.jaut.2014.01.022_bib24","first-page":"143","article-title":"Acute haemorrhagic encephalomyelitis (AHEM): MRI findings","volume":"35","author":"Mader","year":"2004","journal-title":"Neuropediatrics"},{"issue":"15746237","key":"10.1016\/j.jaut.2014.01.022_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1552-6569.2005.tb00311.x","article-title":"Magnetic resonance images on Marburg variant","volume":"15","author":"Susac","year":"2005","journal-title":"J\u00a0Neuroimaging"},{"issue":"3940347","key":"10.1016\/j.jaut.2014.01.022_bib26","first-page":"107","article-title":"Schilder's myelinoclastic diffuse sclerosis","volume":"77","author":"Poser","year":"1986","journal-title":"Pediatrics"},{"issue":"4 Multiple Sclerosis","key":"10.1016\/j.jaut.2014.01.022_bib27","first-page":"944","article-title":"Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica","volume":"19","author":"Wingerchuk","year":"2013","journal-title":"Contin (Minneap Minn)"},{"issue":"Pt 7","key":"10.1016\/j.jaut.2014.01.022_bib28","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awn098","article-title":"Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis","volume":"131","author":"Lucchinetti","year":"2008","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jaut.2014.01.022_bib29","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"5 Multiple Sclerosis","key":"10.1016\/j.jaut.2014.01.022_bib30","first-page":"105","article-title":"Neuromyelitis optica spectrum disorders","volume":"16","author":"Wingerchuk","year":"2010","journal-title":"Contin (Minneap Minn)"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.022_bib31","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/archneurol.2009.178","article-title":"Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays","volume":"66","author":"McKeon","year":"2009","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.022_bib32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.022_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/WNL.0b013e318219dde5","article-title":"IFNbeta-1b may severely exacerbate Japanese opticspinal MS in neuromyelitis optica spectrum: Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment?","volume":"77","author":"Bomprezzi","year":"2011","journal-title":"Neurology"},{"issue":"122","key":"10.1016\/j.jaut.2014.01.022_bib34","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1749-6632.1965.tb20235.x","article-title":"Problems of Experimental Trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis","volume":"31","author":"Schumacker","year":"1965","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.022_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.022_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.022_bib37","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"issue":"Pt 11","key":"10.1016\/j.jaut.2014.01.022_bib38","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","article-title":"Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis","volume":"120","author":"Barkhof","year":"1997","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.022_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1212\/WNL.60.1.27","article-title":"New diagnostic criteria for multiple sclerosis: application in first demyelinating episode","volume":"60","author":"Tintore","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.022_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.10240","article-title":"Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis","volume":"52","author":"Dalton","year":"2002","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.022_bib41","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1212\/01.WNL.0000154520.48391.69","article-title":"Treatment with laquinimod reduces development of active MRI lesions in relapsing MS","volume":"64","author":"Polman","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.022_bib42","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.jaut.2014.01.022_bib43","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1474-4422(07)70176-X","article-title":"MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study","volume":"6","author":"Swanton","year":"2007","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.jaut.2014.01.022_bib44","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/jnnp.2005.073247","article-title":"Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes","volume":"77","author":"Swanton","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.022_bib45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.0b013e3181cec45c","article-title":"MRI criteria for MS in patients with clinically isolated syndromes","volume":"74","author":"Montalban","year":"2010","journal-title":"Neurology"},{"issue":"12063231","key":"10.1016\/j.jaut.2014.01.022_bib46","first-page":"989","article-title":"Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report","volume":"23","author":"Rovira","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.022_bib47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archneurol.2009.49","article-title":"A\u00a0single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis","volume":"66","author":"Rovira","year":"2009","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1016\/j.jaut.2014.01.022_bib48","first-page":"1061","article-title":"Clinical predictors of early second event in patients with clinically isolated syndrome","volume":"256","author":"Mowry","year":"2009","journal-title":"J\u00a0Neurol"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.022_bib49","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1212\/01.wnl.0000234031.30756.a0","article-title":"Are initial demyelinating event recovery and time to second event under differential control?","volume":"67","author":"West","year":"2006","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jaut.2014.01.022_bib50","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archneur.57.7.974","article-title":"Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective study","volume":"57","author":"Achiron","year":"2000","journal-title":"Arch Neurol"},{"issue":"9268","key":"10.1016\/j.jaut.2014.01.022_bib51","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jaut.2014.01.022_bib52","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1177\/1352458508093679","article-title":"Smoking is a risk factor for early conversion to clinically definite multiple sclerosis","volume":"14","author":"Di Pauli","year":"2008","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.022_bib53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.21886","article-title":"Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis","volume":"67","author":"Lunemann","year":"2010","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.jaut.2014.01.022_bib54","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1474-4422(13)70108-X","article-title":"MRI lesions: a surrogate for relapses in multiple sclerosis?","volume":"12","author":"Rudick","year":"2013","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.022_bib55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-2008-1041444","article-title":"Impact of nuclear magnetic resonance imaging on the assessment of multiple sclerosis patients","volume":"6","author":"Jacobs","year":"1986","journal-title":"Semin Neurol"},{"issue":"Pt 6","key":"10.1016\/j.jaut.2014.01.022_bib56","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/brain\/110.6.1579","article-title":"The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study","volume":"110","author":"Ormerod","year":"1987","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.jaut.2014.01.022_bib57","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/brain\/awh126","article-title":"Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes","volume":"127","author":"Dalton","year":"2004","journal-title":"Brain"},{"issue":"Pt 3","key":"10.1016\/j.jaut.2014.01.022_bib58","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/121.3.495","article-title":"The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up","volume":"121","author":"O'Riordan","year":"1998","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jaut.2014.01.022_bib59","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1212\/WNL.38.10.1511","article-title":"Multiple sclerosis: a serial study using MRI in relapsing patients","volume":"38","author":"Isaac","year":"1988","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.022_bib60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00328179","article-title":"Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis","volume":"30","author":"Kappos","year":"1988","journal-title":"Neuroradiology"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.022_bib61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ana.410250107","article-title":"Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients","volume":"25","author":"Willoughby","year":"1989","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.022_bib62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMoa011341","article-title":"A\u00a0longitudinal study of abnormalities on MRI and disability from multiple sclerosis","volume":"346","author":"Brex","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.022_bib63","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1212\/01.WNL.0000082654.99838.EF","article-title":"The utility of MRI in suspected MS: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology","volume":"61","author":"Frohman","year":"2003","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.022_bib64","first-page":"770","article-title":"Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests","volume":"246","author":"Ghezzi","year":"1999","journal-title":"J\u00a0Neurol"},{"issue":"12","key":"10.1016\/j.jaut.2014.01.022_bib65","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/jnnp.51.12.1569","article-title":"The early risk of multiple sclerosis after optic neuritis","volume":"51","author":"Miller","year":"1988","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"Pt 1","key":"10.1016\/j.jaut.2014.01.022_bib66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/brain\/116.1.135","article-title":"The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study","volume":"116","author":"Morrissey","year":"1993","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.022_bib67","first-page":"455","article-title":"Standardized MR imaging protocol for multiple sclerosis: consortium of MS centers consensus guidelines","volume":"27","author":"Simon","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"issue":"7","key":"10.1016\/j.jaut.2014.01.022_bib68","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.7.944","article-title":"High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial","volume":"121","author":"Beck","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.022_bib69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.61.2.217","article-title":"Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis","volume":"61","author":"Minneboo","year":"2004","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.022_bib70","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1191\/1352458505ms1194oa","article-title":"Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis","volume":"11","author":"Scott","year":"2005","journal-title":"Mult Scler"},{"key":"10.1016\/j.jaut.2014.01.022_bib71","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0074-7742(07)79020-7","article-title":"Neuroimaging in multiple sclerosis","volume":"79","author":"Zivadinov","year":"2007","journal-title":"Int Rev Neurobiol"},{"issue":"12","key":"10.1016\/j.jaut.2014.01.022_bib72","first-page":"1447","article-title":"Prospective study of patients presenting with acute partial transverse myelopathy","volume":"250","author":"Cordonnier","year":"2003","journal-title":"J\u00a0Neurol"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.022_bib73","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.291.4.427","article-title":"Migraine as a risk factor for subclinical brain lesions","volume":"291","author":"Kruit","year":"2004","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jaut.2014.01.022_bib74","doi-asserted-by":"crossref","first-page":"b3016","DOI":"10.1136\/bmj.b3016","article-title":"Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis","volume":"339","author":"Morris","year":"2009","journal-title":"BMJ"},{"issue":"18","key":"10.1016\/j.jaut.2014.01.022_bib75","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1056\/NEJMoa070972","article-title":"Incidental findings on brain MRI in the general population","volume":"357","author":"Vernooij","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.022_bib76","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5414\/NP300201","article-title":"Tumefactive demyelination and glioblastoma: a rare collision lesion","volume":"30","author":"Roemer","year":"2011","journal-title":"Clin Neuropathol"},{"issue":"8","key":"10.1016\/j.jaut.2014.01.022_bib77","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nrneurol.2010.93","article-title":"Cortical lesions in multiple sclerosis","volume":"6","author":"Calabrese","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"23","key":"10.1016\/j.jaut.2014.01.022_bib78","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"Lucchinetti","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.jaut.2014.01.022_bib79","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1001\/archneur.64.10.1416","article-title":"Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis","volume":"64","author":"Calabrese","year":"2007","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.022_bib80","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3174\/ajnr.A0645","article-title":"Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging","volume":"28","author":"Nelson","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.022_bib81","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ana.21665","article-title":"Magnetic resonance imaging-based quantitative iron mapping at 7-tesla remains to be elusive in multiple sclerosis","volume":"66","author":"Hasan","year":"2009","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.022_bib82","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/ana.21582","article-title":"Quantitative in\u00a0vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron","volume":"64","author":"Hammond","year":"2008","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.022_bib83","first-page":"262","article-title":"Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla","volume":"28","author":"Kangarlu","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"issue":"12","key":"10.1016\/j.jaut.2014.01.022_bib84","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1212\/WNL.0b013e3181b64bf7","article-title":"In\u00a0vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI","volume":"73","author":"Mainero","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.022_bib85","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ana.21906","article-title":"A\u00a03-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis","volume":"67","author":"Calabrese","year":"2010","journal-title":"Ann Neurol"},{"issue":"22","key":"10.1016\/j.jaut.2014.01.022_bib86","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1212\/WNL.0b013e3181ff96f6","article-title":"Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis","volume":"75","author":"Filippi","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.022_bib87","first-page":"56","article-title":"High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria","volume":"255","author":"Wattjes","year":"2008","journal-title":"J\u00a0Neurol"},{"issue":"7","key":"10.1016\/j.jaut.2014.01.022_bib88","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1212\/WNL.55.7.940","article-title":"Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study","volume":"55","author":"Filippi","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.022_bib89","first-page":"1034","article-title":"Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation","volume":"21","author":"Iannucci","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"10.1016\/j.jaut.2014.01.022_bib90","first-page":"1159","article-title":"Does high field MRI allow an earlier diagnosis of multiple sclerosis?","volume":"255","author":"Wattjes","year":"2008","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.022_bib91","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.clineuro.2005.11.021","article-title":"Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis","volume":"108","author":"Rot","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jaut.2014.01.022_bib92","series-title":"Neurology in clinical practice. Clinical neurophysiology: electroencephalography and evoked potentials","author":"Bradley","year":"2008"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.022_bib93","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1352458509352666","article-title":"Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?","volume":"16","author":"Pelayo","year":"2010","journal-title":"Mult Scler"},{"issue":"12","key":"10.1016\/j.jaut.2014.01.022_bib94","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1001\/archneur.58.12.2044","article-title":"Oligoclonal band number as a marker for prognosis in multiple sclerosis","volume":"58","author":"Avasarala","year":"2001","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2014.01.022_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2009.09.002","article-title":"Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis","volume":"219","author":"Awad","year":"2010","journal-title":"J\u00a0Neuroimmunol"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.022_bib96","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/jnnp.60.5.572","article-title":"A\u00a0prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis","volume":"60","author":"Paolino","year":"1996","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.022_bib97","first-page":"480","article-title":"Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b","volume":"255","author":"Polman","year":"2008","journal-title":"J\u00a0Neurol"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.022_bib98","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1191\/1352458503ms847oa","article-title":"Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings","volume":"9","author":"Sastre-Garriga","year":"2003","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.022_bib99","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/135245850100700603","article-title":"Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS","volume":"7","author":"Tintore","year":"2001","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.022_bib100","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/1352458508100502","article-title":"The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis","volume":"15","author":"Zipoli","year":"2009","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.022_bib101","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement","volume":"62","author":"Freedman","year":"2005","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2014.01.022_bib102","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness","volume":"180","author":"Link","year":"2006","journal-title":"J\u00a0Neuroimmunol"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.022_bib103","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1212\/01.wnl.0000198253.35119.83","article-title":"Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS","volume":"66","author":"Masjuan","year":"2006","journal-title":"Neurology"},{"issue":"13 Pt 2","key":"10.1016\/j.jaut.2014.01.022_bib104","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.wnl.0000280576.73609.c6","article-title":"Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?","volume":"70","author":"Tintore","year":"2008","journal-title":"Neurology"},{"issue":"16194723","key":"10.1016\/j.jaut.2014.01.022_bib105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2005.05.006","article-title":"Soluble adhesion molecules in acute disseminated encephalomyelitis","volume":"33","author":"Martino","year":"2005","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jaut.2014.01.022_bib106","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.022_bib107","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/08916930410001710668","article-title":"Principles of autoantibodies as disease-specific markers","volume":"37","author":"Hawa","year":"2004","journal-title":"Autoimmunity"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jaut.2014.01.022_bib108","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1080\/13547500500214194","article-title":"Biomarkers for diagnosing and monitoring autoimmune diseases","volume":"10","author":"Prince","year":"2005","journal-title":"Biomarkers"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2014.01.022_bib109","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2005.12.006","article-title":"Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis","volume":"244","author":"Schwarz","year":"2006","journal-title":"J\u00a0Neurol Sci"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.022_bib110","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/1352458508101944","article-title":"Anti-alpha-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event","volume":"15","author":"Freedman","year":"2009","journal-title":"Mult Scler"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2014.01.022_bib111","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jneuroim.2009.07.017","article-title":"Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases","volume":"217","author":"Brettschneider","year":"2009","journal-title":"J\u00a0Neuroimmunol"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.022_bib112","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1474-4422(09)70082-1","article-title":"Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis","volume":"8","author":"Rudick","year":"2009","journal-title":"Lancet Neurol"},{"issue":"22","key":"10.1016\/j.jaut.2014.01.022_bib113","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJM199711273372207","article-title":"Management of multiple sclerosis","volume":"337","author":"Rudick","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.jaut.2014.01.022_bib114","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group","volume":"343","author":"Jacobs","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"9585","key":"10.1016\/j.jaut.2014.01.022_bib115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(07)61194-5","article-title":"Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study","volume":"370","author":"Kappos","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.022_bib116","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJMoa022328","article-title":"Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event","volume":"349","author":"Berger","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.022_bib117","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/1352458507077622","article-title":"Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS","volume":"13","author":"Tomassini","year":"2007","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.022_bib118","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0404.2007.00872.x","article-title":"Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort","volume":"116","author":"Greeve","year":"2007","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.022_bib119","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1191\/1352458505ms1187sr","article-title":"Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis","volume":"11","author":"Lim","year":"2005","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.022_bib120","first-page":"160","article-title":"Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF","volume":"254","author":"Kuhle","year":"2007","journal-title":"J\u00a0Neurol"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.022_bib121","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1056\/NEJMoa063602","article-title":"Lack of association between antimyelin antibodies and progression to multiple sclerosis","volume":"356","author":"Kuhle","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.022_bib122","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMc062467","article-title":"Antimyelin antibodies with no progression to multiple sclerosis","volume":"356","author":"Pelayo","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.022_bib123","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/1352458512443092","article-title":"Neurofilaments as biomarkers in multiple sclerosis","volume":"18","author":"Teunissen","year":"2012","journal-title":"Mult Scler"},{"issue":"15","key":"10.1016\/j.jaut.2014.01.022_bib124","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1212\/WNL.0b013e3181a0fe3f","article-title":"Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis","volume":"72","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2014.01.022_bib125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jneuroim.2013.06.010","article-title":"Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis","volume":"262","author":"Fialova","year":"2013","journal-title":"J\u00a0Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2014.01.022_bib126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2013.03.009","article-title":"Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis","volume":"259","author":"Fialova","year":"2013","journal-title":"J\u00a0Neuroimmunol"},{"issue":"8041443","key":"10.1016\/j.jaut.2014.01.022_bib127","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF00588134","article-title":"MRI in acute disseminated encephalomyelitis","volume":"36","author":"Caldemeyer","year":"1994","journal-title":"Neuroradiology"},{"issue":"Pt 12","key":"10.1016\/j.jaut.2014.01.022_bib128","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/brain\/123.12.2407","article-title":"Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children","volume":"123","author":"Dale","year":"2000","journal-title":"Brain"},{"issue":"17188007","key":"10.1016\/j.jaut.2014.01.022_bib129","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejpn.2006.11.007","article-title":"Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse","volume":"11","author":"Mikaeloff","year":"2007","journal-title":"Eur J Paediatr Neurol"},{"issue":"12165620","key":"10.1016\/j.jaut.2014.01.022_bib130","article-title":"Acute disseminated encephalomyelitis in children","volume":"110","author":"Murthy","year":"2002","journal-title":"Pediatrics"},{"issue":"15341905","key":"10.1016\/j.jaut.2014.01.022_bib131","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejpn.2004.05.006","article-title":"What is acute disseminated encephalomyelitis (ADEM)?","volume":"8","author":"Tardieu","year":"2004","journal-title":"Eur J Paediatr Neurol"},{"issue":"9373802","key":"10.1016\/j.jaut.2014.01.022_bib132","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/088307389701200707","article-title":"Acute hemorrhagic leukoencephalitis: recovery and reversal of magnetic resonance imaging findings in a child","volume":"12","author":"Rosman","year":"1997","journal-title":"J\u00a0Child Neurol"},{"issue":"17032866","key":"10.1016\/j.jaut.2014.01.022_bib133","first-page":"1919","article-title":"Acute necrotizing encephalopathy of childhood: correlation of MR findings and clinical outcome","volume":"27","author":"Wong","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.022_bib134","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00415-013-6838-x","article-title":"Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study","volume":"260","author":"D'Alessandro","year":"2013","journal-title":"J Neurol"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:09:41Z","timestamp":1760256581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841114000250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":134,"alternative-id":["S0896841114000250"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2014.01.022","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2014.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}